Browse drugs

…t (2%), and paediatric (2%).Conclusion and Relevance Nearly all linezolid prescriptions met at least one criterion for TDM, with around 6…

…78.7%), followed by semaglutide (69.6%), exenatide (49.6%), and liraglutide (39.6%).Cox regression analysis (reference: dulaglutide) showed…

…Background In Study 309/KEYNOTE-775 ( NCT03517449), lenvatinib+pembrolizumab versus chemotherapy significantly improved progre…

…label aspirin for days 2–7. Both groups will receive open-label aspirin (100 mg daily) for days 8–90.Study outcomes The primary efficac…

…emotherapy, pembrolizumab-based chemoimmunotherapy (Pembro) and nivolumab plus ipilimumab with or without two cycles of platinum-doublet …

…to mid 2000s. These trends, alongside decreasing use of several antihypertensive drugs and in the context of worsening population level control, may r…

…ced from 5.3 at baseline, to 2.52 with mexiletine and 2.62 with lamotrigine. The most common adverse event was indigestion/reflux with both…

… Published online 2025 Jun 12.Tomsitz D, Ruf T, Heppt M, et al. Tebentafusp in patients with metastatic uveal melanoma: a real-life retrosp…

…strate that the increased HER2 affinity of the IgE therapeutic, EPS 232, improved anti-tumour responses and indicate that EPS 232 could…

…47 Bi-specific antibody. Sci Rep. 2024;14(1):28201.Ke H, et al. HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent an…

…ized mouse model through interaction with human APC, suggesting NY-ESO specific CD4+ T cells could target MHC II negative tumors.Abstr…

…histology displayed a more pronounced immunological response to CAN-2409 treatment compared to patients with SQ histology. Improved immu…